Lipiodol as an Imaging Biomarker of Tumor Response After Conventional Transarterial Chemoembolization: Prospective Clinical Validation in Patients with Primary and Secondary Liver Cancer.

ABSTRACT:

SUBMITTER: Miszczuk MA 

PROVIDER: S-EPMC7036424 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature